1999 completed, 572 unknown, 344 recruiting, 283 terminated. 880 Not applicable, 737 Phase 2, 460 Phase 1, 434 Phase 3, 253 Phase 4.
Follow Retinal Diseases: new trials by email Literature Review of Retinal Diseases trials Research Report on Retinal Diseases
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Remapping Text in Sentence and Word Tasks to Aid Reading With Central Vision Loss Personalised Remapping Training, RSVP personalized remappi, Reading text in the wild with remapping - Macular Degeneration, Central Visual Impairment | Not applicable | Not yet recruiting | University of Minnesota | 216 | 2027-06-01 | 2026-10-29 |
| Eye Health Intervention Study in Upper Manhattan Intervention, Usual Care - Glaucoma, Suspect, Diabetic Retinopathy | Not applicable | Withdrawn | Columbia University | 2027-04-01 | 2026-05-29 | |
| Safety and Clinical Performance of the LENTIS® MAX LS-313 MF80 Compared With the Monofocal L-313 in Cataract Patients With Late Age-Related Macular Degeneration: A Multicenter Comparative Clinical Investigation. Intraocular Lens - Cataract, AMD - Age-Related Macular Degeneration | Not applicable | Not yet recruiting | Teleon Surgical B.V. | 35 | 2027-02-01 | 2026-11-04 |
| Non-invasive Ultrasound Retinal Stimulation for Vision Restoration Non-invasive ultrasound retinal stimulation Device - Age-Related Macular Degeneration, Retinitis Pigmentosa | Not applicable | Not yet recruiting | University of Southern California | 5 | 2027-01-10 | 2026-01-08 |
| MIND-AMD Study: a Multidisciplinary Investigation of Neuroretinal Damage in Age-related Macular Degeneration. Age-Related (Dry) Macular Degeneration, Age-Related Macular Degeneration (AMD) | Not yet recruiting | IRCCS San Raffaele | 160 | 2027-01-02 | 2026-09-29 | |
| Prevalence of Age-Related Macular Degeneration in Assiut University Hospitals OCT - clear - Age-Related Macular Degeneration (AMD) | Not yet recruiting | Assiut University | 90 | 2027-01-01 | 2026-10-21 | |
| The GEIR (Grupo español de Ictus Retina) Registry: Rationale and Design of the First Nationwide Multicentre Retinal Stroke Registry in Spain Retinal Artery Occlusion, Central Retinal Artery Occlusion | Not yet recruiting | Germans Trias i Pujol Hospital | 500 | 2027-01-01 | 2026-11-06 | |
| Heterologous Cord Blood-Derived Red Blood Cell for Transfusion in Extremely Preterm Infants Cord Blood Red Blood Cells, Standard Adult Donor Red Blood Cells - Extremely Premature Infant, Anemia Neonatal | Not applicable | Not yet recruiting | Hospital Clinic of Barcelona | 280 | 2027-01-01 | 2026-11-09 |
| Efficacy of Aflibercept With Sequential Laser Photocoagulation for Macular Edema Secondary to Retinal Artery Macroaneurysm. evaluate the efficacy and safety of a sequential treatment protocol-comprising three consecutive monthly intravitreal injections of aflibercept 8 mg followed by focal laser photocoagulation targeted a - Retinal Arterial Macroaneurysm | Not yet recruiting | New Valley University | 15 | 2027-01-01 | 2026-11-10 | |
| Retinopathy of Prematurity - Visual Function and Retinal Structure Retinopathy of Prematurity (ROP), Prematurity Complications | Not yet recruiting | Oslo University Hospital | 140 | 2027-01-01 | 2026-11-10 | |
| 24-Month Trial of NPI-001 for the Preservation of Photoreceptors in Retinitis Pigmentosa Associated With Usher Syndrome N-acetylcysteine amide, Placebo - Retinitis Pigmentosa (RP), Usher Syndrome | Phase 3 | Not yet recruiting | Nacuity Pharmaceuticals, Inc. | 80 | 2026-12-01 | 2026-07-01 |
| Faricimab for Chronic Central Serous Chorioretinopathy: A Randomized Sham-Controlled Trial Faricimab, Sham - Central Serous Chorioretinopathy (CSC) | Phase 2 | Not yet recruiting | Singapore National Eye Centre | 50 | 2026-12-01 | 2026-07-02 |
| The Safety and Efficacy of Intravitreal Topotecan for the Treatment of Proliferative Vitreoretinopathy Topotecan - Proliferative Vitreoretinopathy, Proliferative Vitreo-Retinopathy | Phase 1 | Not yet recruiting | Massachusetts Eye and Ear Infirmary | 50 | 2026-12-01 | 2026-10-16 |
| Analyzing Retinal Microanatomy in Retinopathy of Prematurity to Improve Care Ultra-widefield Optical Coherence Tomography (UWF-OCT), Wide-field ophthalmic imaging system - Retinopathy of Prematurity (ROP) | Not applicable | Recruiting | Duke University | 175 | 2026-12-01 | 2026-09-17 |
| Morpho-functional Evaluation of the Retina and Choroid Using Multimodal Imaging in Healthy Subjects and Patients With Retino-choroidal Diseases Retinal Diseases, Choroidal Diseases | Not yet recruiting | Fondazione G.B. Bietti, IRCCS | 125 | 2026-12-01 | 2026-11-12 | |
| Intensive Glycemic Control Combined With Brolucizumab for Diabetic Macular Edema Intensive Glycemic Management, Brolucizumab - Diabetic Macular Edema, Diabetic Retinopathy | Not applicable | Not yet recruiting | The Fourth Affiliated Hospital of Zhejiang University School of Medicine | 100 | 2026-11-30 | 2026-11-13 |
| Adaptive Optics Scanning Light Ophthalmoscopy (AOSLO) and Microperimetry (MP) Sub-study Adaptive Optics Scanning Light Ophthalmoscopy, Microperimetry, Optical Coherence Tomography - Geographic Atrophy | Not applicable | Enrolling by invitation | University of Wisconsin, Madison | 10 | 2026-11-05 | 2026-10-26 |
| MacuMira Microcurrent Stimulation for Dark Adaptation in Dry Age-Related Macular Degeneration Transpalpebral microcurrent electrical stimulation - Age-Related Macular Degeneration (AMD) | Not applicable | Not yet recruiting | Clarity Eye Institute | 50 | 2026-11-04 | 2026-11-04 |
| A Phase 1, First-in-Human Study of CITY-RBP4 in Healthy Volunteers and STGD1 Participants CITY-RBP4, Placebo - Stargardt Disease 1, STGD1 | Phase 1 | Recruiting | City Therapeutics | 48 | 2026-11-04 | 2026-11-12 |
| OCT Macula Biomarkers Before Silicone Oil Removal and Visual Outcome After Silicone Oil Removal Retinal Detachment, Macular Edema | Not yet recruiting | Assiut University | 30 | 2026-11-01 | 2026-10-08 |
Showing 20 of 3611. Sign in to see all of them.
Macular Degeneration (1174) · Diabetic Retinopathy (685) · Macular Edema (418) · Retinal Vein Occlusion (276) · Retinitis Pigmentosa (268) · Diabetes Mellitus (199) · Geographic Atrophy (179) · Retinopathy of Prematurity (167) · Retinal Detachment (162) · Choroidal Neovascularization (153) · Eye Diseases (138) · Retinal Perforations (137) · Retinal Degeneration (130) · Epiretinal Membrane (123)
Eye Diseases (3473) · Retinal Degeneration (1886) · Cardiovascular Diseases (1021) · Vascular Diseases (1013) · Endocrine System Diseases (769) · Diabetic Angiopathies (681) · Diabetes Complications (675) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (640) · Pathological Conditions, Signs and Symptoms (574) · Eye Diseases, Hereditary (560) · Diabetes Mellitus (556) · Macular Degeneration (527) · Genetic Diseases, Inborn (461) · Nervous System Diseases (354)
Ranibizumab (336) · aflibercept (206) · Bevacizumab (126) · salicylhydroxamic acid (79) · Dexamethasone (61) · Calcium Dobesilate (54) · Triamcinolone Acetonide (51) · Vitrectomy (49) · Tomography, Optical Coherence (42) · Verteporfin (34) · pegaptanib (29) · Ganciclovir (27) · Carboplatin (26) · brolucizumab (26) · Intravitreal Injections (24)
National Eye Institute (NEI) (121) · Novartis Pharmaceuticals (79) · Bayer (53) · Medical University of Vienna (41) · Allergan (39) · Johns Hopkins University (32) · Sun Yat-sen University (32) · Hoffmann-La Roche (30) · Shahid Beheshti University of Medical Sciences (27) · Genentech, Inc. (26) · Alcon Research (25) · Asociación para Evitar la Ceguera en México (25) · Duke University (25) · Association for Innovation and Biomedical Research on Light and Image (24) · University of Sao Paulo (24)
United States (1425) · France (283) · China (260) · United Kingdom (251) · Germany (240) · Canada (211) · Italy (189) · Austria (151) · Australia (142) · Spain (136) · Israel (117) · South Korea (106) · Switzerland (94) · Brazil (89) · Netherlands (85)
Emily Y Chew, M.D. (11) · Hamid Ahmadieh, MD (11) · Peter A Campochiaro, MD (10) · Hugo Quiroz-Mercado, MD (9) · Pablo Velazquez-Martin, MD (9) · Jason Hsu, MD (8) · Cynthia A Toth, MD (7)
PMID 37314061, PMID 40522203, PMID 37702300, PMID 32408387, PMID 32374423, PMID 32573764, PMID 36912792, PMID 40547876, PMID 22281388, PMID 23049090, PMID 25458728, PMID 26089210, PMID 30957581, PMID 32844399, PMID 34934034, PMID 39758130, PMID 21571677, PMID 23084240, PMID 23706949, PMID 24768239, PMID 25439614, PMID 25677668, PMID 30194931, PMID 31042791, PMID 32633861, PMID 33206392, PMID 33331670, PMID 35085502, PMID 36246941, PMID 36774994, PMID 37260074, PMID 37261916, PMID 38254722, PMID 39102242, PMID 39207600, PMID 11297486, PMID 15808240, PMID 17021318, PMID 17021319, PMID 18441312, PMID 19255158, PMID 19365036, PMID 19506188, PMID 19953081, PMID 20008710, PMID 20189654, PMID 20378094, PMID 20427088, PMID 20580421, PMID 20683380
2014 (18), 2019 (17), 2018 (14), U10EY014231 (9), 2017 (8), U10EY018817 (8), 2009 (7), 2016 (7), 2025 (7), 2015 (6), U10EY014229 (6), U10HD021385 (5), U10HD027851 (5), U10HD027853 (5), U10HD027856 (5)